Individually customised therapies for every patient this is the vision of the future which numerous companies, research institutions, and clusters focusing on precision medicine in Saxony are working along the entire value creation chain. They are primarily active in oncology and have gained national and international acclaim and renown both in highly specialised cancer diagnostics and innovative treatment methods.
Spain: An overview over a sector that has proven to be strategic
BackgroundAfter two years of unprecedented growth driven by the pandemic, investment attracted by Spanish biotech companies has stabilised, and they face significant challenges, positioning biotechnology as a strategic sector for Spain.
Mogrify Ltd extends Series A financing to $46m
Latest NewsBritish in-vivo cell programming specialist Mogrify Ltd has added US$10m to its US$36m Series A financing.
Seamless Transition: Elevate Immune Cell Expansion from RUO to GMP
ProductsCell Culture Grade AB Serum that can be customised to your specifications.
Joining forces for mRNA breakthrough
Latest NewsDyadic International Inc. and bYoRNA SAS partnered to advance innovative bioproduction technologies for scaling up the production of therapeutic mRNA from C1-Cells.
‘Older & Fatter’ megatrend is a time waster
OpinionStock markets love investment concepts, calling the robust ones ‘megatrends’. Golden ageing is one such megatrend banking on the fact that business can extract more from people living longer. Such megatrend investments help – up to the moment when rising interest rates crash the party.
'Older & Fatter' megatrend is a time waster
OpinionStock markets love investment concepts, calling the robust ones ‘megatrends’. Golden ageing is one such megatrend banking on the fact that business can extract more from people living longer. Such megatrend investments help – up to the moment when rising interest rates crash the party.
Saxony Focuses on Precision Medicine
Sponsored PublicationsIndividually customised therapies for every patient this is the vision of the future which numerous companies, research institutions, and clusters focusing on precision medicine in Saxony are working along the entire value creation chain. They are primarily active in oncology and have gained national and international acclaim and renown both in highly specialised cancer diagnostics and innovative treatment methods.
SeaBeLife secures €1.2m in funding
Latest NewsBiotech company, specialising in cell necrosis prevention, has announced a successful funding round, securing €1.2m in additional seed funding.
BioSpain breaking records
Latest NewsWith more than 2,100 attendents, 4,700 partnering meetings so far, BioSpain 2023 is set to break records.
Pierre Fabre Laboratories collaborate with Vernalis
Latest NewsPierre Fabre Laboratories, a leading French medical and beauty care company and Vernalis (R&D) Ltd, a fully owned subsidiary of HitGen Inc. and a specialist in drug discovery announce a long-term partnership for oncology drug discovery.